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EFFECTS OF VITAMIN C SUPPLEMENTATION ON ACUTE PHASE CHAGAS DISEASE IN 
EXPERIMENTALLY INFECTED MICE WITH Trypanosoma cruzi QM1 STRAIN
Ricardo Guimarães MARIM(1), Alex Silva de GUSMÃO(1), Roberto Esteves Pires CASTANHO(1), Rafael DEMINICE(3),  
Altino Luiz Silva THEREZO(2), Alceu Afonso JORDÃO JÚNIOR(3) & Luciamare Perinetti Alves MARTINS(1)
SUMMARY
The tissue changes that occur in Chagas disease are related to the degree of oxidative stress and antioxidant capacity of affected 
tissue. Studies with vitamin C supplementation did not develop oxidative damage caused by Chagas disease in the host, but other 
studies cite the use of peroxiredoxins ascorbate - dependent on T. cruzi to offer protection against immune reaction. Based on these 
propositions, thirty “Swiss” mice were infected with T. cruzi QM1 strain and treated with two different vitamin C doses in order to study 
the parasitemia evolution, histopathological changes and lipid peroxidation biomarkers during the acute phase of Chagas disease. The 
results showed that the parasite clearance was greater in animals fed with vitamin C overdose. There were no significant differences 
regarding the biomarkers of lipid peroxidation and inflammatory process or the increase of myocardium in animals treated with the 
recommended dosage. The largest amount of parasite growth towards the end of the acute phase suggests the benefit of high doses 
of vitamin C for trypomastigotes. The supplementation doesn’t influence the production of free radicals or the number of amastigote 
nests in the acute phase of Chagas disease.
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INTRODUCTION
In Brazil, approximately three million individuals are infected by 
Trypanosoma cruzi, with a predominance of chronic cases resulting from 
past infections. However, in recent years the occurrence of acute Chagas 
disease has been observed in states of Bahia, Ceara, Piaui, Sao Paulo and 
Santa Catarina, with a higher frequency of cases and outbreaks in some 
states of the Amazon Region6.
In Chagas disease, it is observed that much of the damage to the host 
is caused by excess free radical production in tissues infected by T. cruzi. 
The reactive oxygen in the species metabolism (ROS) can damage any cell 
component, but the ones most affected are the cell membranes. In order 
to combat free radicals, aerobic biological systems use two mechanisms, 
one of which works with compounds such as reduced glutathione (GSH), 
superoxide dismutase (SOD), catalase, glutathione peroxidase (GSH-Px) 
and vitamin E, which has the ability to neutralize ROS before they cause 
tissue damage. The other mechanism is performed by ascorbic acid, 
glutathione reductase (GSH-Rd) and GSH-Px, which repair the damage 
caused by free radicals, reversing membrane lipid peroxidation9.
The thiobarbituric acid reactive substances (TBARS) are compounds 
produced after membrane lipid peroxidation, and protein carbonyl is an 
oxidation product of cellular proteins. Both oxidative stress products are 
caused by Chagas disease. MAÇAO et al.12 revealed reduced levels of 
TBARS and protein carbonyl in patients with Chagas cardiomyopathy 
who received supplemental vitamin C and E, showing a strong indication 
that these non-enzymatic antioxidants are effective in neutralizing the 
oxidative insult caused by Chagas disease.
Recent studies have shown that some parasites can decrease 
ascorbate-dependent antioxidative enzymes using the ascorbic acid 
present in infected tissues, and can therefore protect themselves from the 
oxidizing action of ROS and reactive nitrogen species (RNS) produced 
by host inflammatory cells11,14. In Saccharomyces cerevisiae, Plasmodium 
falciparum and T. cruzi peroxiredoxines (prx) type 1-Cys become active 
in peroxide detoxification when reduced by ascorbic acid. T. cruzi is 
lacking in catalase, superoxide dismutase and glutathione peroxidase 
selenocysteine-dependent and therefore depends on prx to decompose 
peroxides produced by host macrophages11,14.
Based on these suggestions we propose the respective study in mice 
experimentally infected with T. cruzi QM1 strain in the acute phase of 
Chagas disease.
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MATERIALS AND METHODS
1. Infection of mice: Thirty “Swiss” male mice, each 20 days old 
were intraperitoneally infected with 5.0 x 104 trypomastigotes of T. cruzi 
QM1 strain, characterized by MARTINS et al.13, using blood from other 
mice previously infected. Separated at random, three groups of 10 mice 
each were designated R, S, P. The Recommended group (R) received 
the recommended dose of vitamin C per gram of weight, the Overdose 
group (S) received an overdose of vitamin C per gram of weight and 
the Placebo group (P) received mineral water. The animals were kept in 
individual cages to facilitate handling and they were fed with Nuvilab 
CR-1® and water ad libitum.
2. Calculation of the vitamin C dose and treatment: Considering 
that the recommended daily dose of vitamin C for a man of 70,000 g is 
60 mg4,18, which results in approximately 8.6 x 10-4 mg of vitamin C per 
gram of weight, a D60 dose of vitamin C equal to 8.6 x 10-4 mg / g, dissolved 
in 10 µL of mineral water was orally given to group R daily. Since various 
brands available for sale provide a dose of 500 mg of vitamin C daily for a 
man of 70,000 g, which results in approximately 7.14 x 10-3 mg of vitamin 
C per gram of weight; a dose of vitamin C equal to 7.14 x 10-3 mg/g, 
dissolved in 10 µL of mineral water was administered orally to group 
S D500 on a daily basis. Group P received 10 µL of mineral water daily. 
Groups R, S and P received this treatment for 60 days. Each morning, 
all mice were treated and orally received 10 µL of vitamin C D60, D500 
or mineral water using a Gilson automatic pipette.
The treatment form, care and euthanasia of mice was in accordance 
with Cobea rules20. This study was approved by the Ethics Committee 
of the Faculty of Medicine of Marília (FAMEMA), protocol nº 133/10.
3. Study of parasitemia: During 60 days the parasitemia of each 
mouse from groups R, S and P was determined twice a week following 
the BRENER3 method, starting on the 7th day post- infection, and totaling 
10 counts for each animal.
4. Histopathological study: For histopathological analysis a 
fragment of heart, colon and skeletal muscle tissue taken from the 
thigh of all mice of groups R, S and P was collected on the 60th day 
post- infection. The tissues were embedded in paraffin and 5 µm 
sections were stained with hematoxylin-eosin and examined under a 
light microscope with 400 times magnification. For each fragment five 
sequential histological sections were performed, which were analyzed 
and graded for inflammation process and amastigotes nests, a total of 
10 high magnification fields were performed for each type of tissue. 
A semiquantitative scale from zero to three was used to grade 
the inflammatory process, amastigote nests and necrosis. “Zero” was 
considered as – the absence of inflammation, necrosis and amastigote 
nests, “one” – mild inflammation, and rare amastigote nests and necrosis, 
“two” – moderate inflammation, moderate number of amastigote nests 
and necrosis, and “three” – intense inflammation, frequent amastigote 
nests and necrosis. 
5. Biochemical analysis: Blood was collected by cardiac puncture 
into heparin, centrifuged at 1000 g and 200 µL plasma portion, and 
was immediately acidified with 800 µL of 5% trichloroacetic acid for 
subsequent ascorbic acid determination. Plasma and homogenate were 
stored at -80 ° C. One fragment of heart muscle was immediately frozen 
in liquid nitrogen and subsequently stored at -80 ° C.
Thiobarbituric acid reactive substances (TBARS), a lipid peroxidation 
biomarker, were placed in plasma and heart muscle using a method 
adapted from COSTA et al. (2006)5. A portion of homogenated plasma 
or muscle (100 µL) was mixed with 1 mL of a solution containing 15% 
(w/v) trichloroacetic acid, 0.38% (w/v) thiobarbituric acid and 0.25 mol/L 
of hydrochloric acid (HCl). The mixture was heated at 100 °C for 
40 minutes, and the supernatant was read at 535 nm. Total concentration 
of TBARS was determined using the absorbance difference between 
samples and the standard solution of MDA.
Total peroxides, also a lipid peroxidation biomarker, were determined 
using the FOX method in cardiac muscle and plasma, as described by 
SÖDERGREN et al. (1998)19. A solution of 100 µmol/L xylenol orange, 
4 mmol/L butylated hydroxytoluene, 25 mmol/L sulfuric acid and 
250 µmol/L ammonium ferrous sulfate in a HPLC grade methanol:water 
(9:1 v/v) was added to 100 µL of plasma or muscle homogenate. The 
mixture was incubated for 30 min in darkness and at room temperature. 
Absorbance of the supernatant was measured at 560 nm. Total peroxides 
in muscle and plasma were determined comparing them with the standard 
H2O2 curve.
The ascorbic acid concentration in plasma and heart muscle 
was determined according to BESSEY (1960)2. 100 µL of solution 
containing 2,4-dinitrophenylhydrazine (2%), thiourea (5%) and copper 
sulphate (0.6%) in sulfuric acid (25%) was added to 300 µL of acidified 
plasma. After four hours incubation in a 37 ˚C water bath, 200 µL of 
sulfuric acid (65%) was added. The 20 min reaction was performed 
at room temperature and the reading was performed at 520 nm in a 
spectrophotometer (Spectramax M5, Molecular Device), and compared 
to a standard ascorbic acid curve.
Statistical analysis: The results of the biochemical analysis were 
analyzed by descriptive statistical methods and statistical inference using 
the Student’s t test and Fisher. The significance level used was 0.05. 
In order to analyze the histopathologic, descriptive data analysis, the 
following tests were used: Kruskal-Wallis test (ANOVA non-parametric) 
with post-test. Significance level was 5%.
RESULTS
1. Study of parasitemia: Figure 1 shows that all groups had 
parasitemia on the 7th day post-infection, and it appeared larger in group 
S than in groups R and P, with statistically significant results. However, 
from the 13th to the 40th day there was an increase observed in groups P and 
R, with more significant results on the 13th and 16th days than in group S. 
However, at the end of the acute phase, group S showed a tendency to 
stabilize the parasitemia in higher values than in groups R and P. It was 
observed that on the 50th day group P showed lower parasitemia than 
groups R and S with a significant difference. An isolated analysis of the 
groups R and P showed a statistically significant difference only on day 
50th with higher parasitemia in group R.
2. Histopathological analysis: Table 1 shows that the three groups 
showed inflammation in all tissues examined, although at a lesser intensity 
in the heart muscle. Group R showed a stronger inflammatory process in 
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heart muscle than groups P (p = 0.0167) and S (p = 0.0377). The presence 
of amastigote nests was observed in both skeletal muscle and colon tissue.
3. Biochemical analysis: The analysis in Tables 2 and 3 show that 
in the acute phase there was no statistical difference between groups in 
any analyzed parameters (p > 0.05 for all comparisons).
DISCUSSION
According to WEYERS et al.22 and RIBEIRO17 adequate doses of 
vitamin C can act against lipid peroxidation caused by ROS formed 
naturally or by exogenous compounds in mice, because in electron 
donating the ascorbate chemically reduces lipid after the peroxidation 
process. However, the studies of PADAYATTY et al.15 and FERREIRA 
& MATSUBARA8 showed that depending on the vitamin C dose, it can 
act as pro-oxidant.
For LEVINE et al.10, the plasma levels of vitamin C plasmatic are 
maintained when dose fractionation occur at regular intervals of less 
than 1.5 h. For BENKE1 the plasma concentration of ascorbic acid 
depends on the dose and administration method, it reaches a saturation 
plateau within 3 hours of 1g vitamin C having been administered orally 
and decays linearly within 24 hours. The research of PADAYATTY et 
al.16 performed on human plasma did not show significant differences 
when different doses of vitamin C were administered orally, whereas a 
significant increase in plasma levels was observed when there was an 
intravenous application of same dosages. 
The researches above could explain the results obtained in this present 
study where the concentration of vitamin C in plasma and tissue was 
similar in all groups, without significant difference between groups R and 
S in comparison with group P, probably because mice supplementation 
had been performed orally in the morning, in a single daily dose and 
plasma and tissues collection for this analysis had been done at the end 
of the 60th day.
Table 1
Histopathological analysis in cardiac muscle, skeletal muscle and colon tissue during the acute phase of experimental infection by T. cruzi QM1  
strain in mice treated with two different doses of vitamin C and placebo
Groups
Cardiac Muscle Skeletal Muscle Colon
Inflammation Amastigote Inflammation Amastigote Necrosis Inflammation Amastigote
P 0.22 0.00 1.00 1.00 0.56 0.89 0.89
R 0.78 0.00 1.56 1.22 0.89 0.56 1.33
S 0.30 0.00 1.50 1.00 1.50 1.00 1.30
P = animals treated with 10 µL of mineral water; R = animals treated with D60 dose of vitamin C equal to 8.6 x 10-4 mg/g; S = animals treated with D500 dose of 
vitamin C equal to 7.14 x 10-3 mg/g.
Table 2
Plasma levels of TBARS, total peroxide and ascorbic acid of mice treated 
with two different doses of vitamin C and placebo during the acute phase of 
experimental infection by T. cruzi QM1 strain. Variables were expressed as 
mean ± standard deviation 
Variables P R S
TBARS (µmol/mL) 50.1 ± 7.0 51.9 ± 11.5 54.7 ± 6.4
Total peroxide 
(Mmol/H2O2 equivalent)
104.5 ± 35.9 139.9 ± 50.0 99.9 ± 28.6
Ascorbic acid (mg/dL) 0.26 ± 0.05 0.29 ± 0.14 0.24 ± 0.05
P = animals treated with 10 µL of mineral water; R = animals treated with D60 
dose of vitamin C equal to 8.6 x 10-4 mg/g; S = animals treated with D500 dose 
of vitamin C equal to 7.14 x 10-3 mg/g.
Table 3
TBARS, total peroxide and ascorbic acid in mice miocardium treated with 
two different doses of vitamin C and placebo during the acute phase of 
experimental infection by T. cruzi QM1 strain. Variables were expressed as 
mean ± standard deviation
Variables P R S
TBARS (µmol/g prot) 301.1 ± 74.7 298.0 ± 83.9 359.1 ± 72.8
Total peroxide 
(mmol H2O2 equivalent/ 
g prot)
528.8 ± 112.0 637.8 ± 130.6 538.2 ± 70.8
Ascorbic acid (µg/g prot) 5.10 ± 0.51 5.80 ± 1.90 6.36 ± 4.02
P = animals treated with 10 µL of mineral water; R = animals treated with D60 
dose of vitamin C equal to 8.6 x 10-4 mg / g; S = animals treated with D500 dose 
of vitamin C equal to 7.14 x 10-3 mg / g.
Fig. 1 - Parasitemia curve of blood trypomastigotes/5 µL number by log mean performed 
during the acute phase of T. cruzi QM1 strain infection in mice treated with two different 
doses of vitamin C and placebo.
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Considering the researches cited earlier and how the animals 
studied were treated, we may conclude that vitamin C did not interfere 
in ROS action and production, as would appear to be the case in 
the histopathological analysis, which showed a similar amount of 
inflammation in skeletal muscle and colon tissue in groups R and S as 
in group P. The reduced inflammation and absence of amastigote nests 
in the heart may be related to a strain characteristic as well as the fact 
observed by WEN et al.21 and DI MEO et al.7 who found an improved 
antioxidant defense system in the hearts of normal mice in comparison 
with their skeletal muscle and colon tissue. The lower antioxidant 
efficiency of skeletal muscle may be one explanation for the occurrence of 
larger damage to this tissue in the acute phase of the illness in this work.
Similarly, the multiplication of the parasite was not affected by 
different doses of vitamin C, which can be observed by the finding of 
similar numbers of amastigote nests in the skeletal muscle and colon tissue 
among the three groups. According to MONTEIRO et al.14 the parasite has 
mechanisms which allow it to benefit from the action of ascorbic acid, it can 
also use the plasmatic ascorbate present in mammalians to reduce parasite 
prx and thereby protect itself from peroxides produced by the host, despite 
that LOGAN et al.11 showed that although T. cruzi is not able to capture 
extracellular vitamin C to maintain their enzymes prx active, it is able to 
synthesize vitamin C from galactono-γ-lactone and D-arabino-γ-lactone.
At this stage of the disease it was not observed total peroxides and not 
decreasing TBARS levels in groups R and S compared to P group, although 
studies with vitamin E supplementation (800 IU / day) and vitamin C (500 
UI/day) had shown TBARS levels reduction in patients with the chronic 
form of Chagas’ disease12. The non-animal supplementation with vitamin 
E in this study may have been the reason why TBARS levels did not reduce 
in groups R and S, because vitamins C and E act synergistically, blocking 
lipid peroxidation propagation in cell membranes12.
We observed that group S parasitemia was lower than in groups 
P and R from the 10th to the 43rd day, suggesting that the vitamin C 
overdose orally administered to this group possibly allowed the immune 
system to temporarily take contol of parasitic multiplication in the blood, 
but not in other tissues, indicating that a single daily administration of 
vitamin C was not enough to maintain the concentration needed to avoid 
oxidative stress. Moreover, the fact that group S had a higher parasite 
growth at the end of the acute phase suggests that trypomastigotes can 
benefit from this higher dosage, as proposed by MONTEIRO et al.14 
and LOGAN et al.11.
RESUMO
Efeitos da suplementação de vitamina C sobre a fase aguda da 
doença de Chagas em camundongos experimentalmente infectados 
pela cepa QM1 de Trypanosoma cruzi
As alterações teciduais que ocorrem na doença de Chagas estão 
relacionadas ao grau de estresse oxidativo e à capacidade antioxidante 
do tecido afetado. Estudos realizados com suplementação de vitamina 
C revelaram redução no dano oxidativo causado no hospedeiro pela 
doença de Chagas, porém outros estudos citam o uso de peroxiredoxinas 
dependentes de ascorbato pelo T. cruzi para se proteger da ação imune. 
Com base nessas proposições, trinta camundongos “Swiss” foram 
infectados com a cepa QM1 de T. cruzi e tratados com duas diferentes 
doses de vitamina C para estudar a evolução da parasitemia, alterações 
histopatológicas e dosagem de biomarcadores de peroxidação lipídica 
durante a fase aguda da doença de Chagas. Os resultados mostraram que 
a parasitemia foi maior nos animais que receberam uma superdosagem de 
vitamina C. Não houve diferenças significativas quanto aos biomarcadores 
de peroxidação lipídica e houve maior processo inflamatório no miocárdio 
dos animais tratados com dosagem recomendada. O maior crescimento 
parasitário ao fim da fase aguda sugere benefício de altas doses de 
vitamina C aos tripomastigotas. A suplementação não exerceu influência 
sobre a produção de radicais livres e o número de ninhos de amastigotas 
na fase aguda da doença de Chagas.
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